Energy metabolism in amyotrophic lateral sclerosis (Q37805077)

23 August 2017

title

Energy metabolism in amyotrophic lateral sclerosis (English)

1 reference

amyotrophic lateral sclerosis

23 August 2017

main subject

0 references

Albert C Ludolph

1 reference

23 August 2017

Pierre-François Pradat

series ordinal

object named as

Pierre-François Pradat

1 reference

23 August 2017

Luc Dupuis

1 reference

23 August 2017

Jean-Philippe Loeffler

series ordinal

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21035400

17 August 2024

publication date

27 October 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S1474442210702246?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S1474-4422(10)70224-6

https://api.elsevier.com/content/article/PII:S1474442210702246?httpAccept=text/plain

17 August 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S1474-4422(10)70224-6

17 August 2024

1 reference

23 August 2017

1 reference

23 August 2017

1 reference

23 August 2017

page(s)

75-82

1 reference

Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Causes of death in a post-mortem series of ALS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Toxic models of upper motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Genetics of motor neuron disorders: new insights into pathogenic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Nutritional status is a prognostic factor for survival in ALS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Nutritional assessment and survival in ALS patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Hypermetabolism in ALS: correlations with clinical and paraclinical parameters

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Dyslipidemia is a protective factor in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

APOE: a potential marker of disease progression in ALS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Lower serum lipid levels are related to respiratory impairment in patients with ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Impaired glucose tolerance in patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

The metabolic hypothesis in amyotrophic lateral sclerosis: insights from mutant Cu/Zn-superoxide dismutase mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Increased sensitivity of myoblasts to oxidative stress in amyotrophic lateral sclerosis peripheral tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Mitochondrial respiratory chain dysfunction in muscle from patients with amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Muscular mitochondrial function in amyotrophic lateral sclerosis is progressively altered as the disease develops: A temporal study in man

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Mitochondrial respiratory chain function in skeletal muscle of ALS patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Fruit and vegetable intake and risk of amyotrophic lateral sclerosis in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Nutritional status and risk of amyotrophic lateral sclerosis in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Diet and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Weight loss in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Prognostic factors in ALS: A critical review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

ALS disease onset may occur later in patients with pre-morbid diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Association of apolipoprotein E ∈4 allele with bulbar-onset motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Lack of association between apolipoprotein E genotype and sporadic amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Apolipoprotein E epsilon 4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

The gene coding for PGC-1alpha modifies age at onset in Huntington's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Degeneration of corticospinal and bulbospinal systems in the superoxide dismutase 1(G93A G1H) transgenic mouse model of familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

An animal model of oral dysphagia in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Energy intake and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Caloric restriction shortens lifespan through an increase in lipid peroxidation, inflammation and apoptosis in the G93A mouse, an animal model of ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Transient caloric restriction in early adulthood hastens disease endpoint in male, but not female, Cu/Zn-SOD mutant G93A mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Up‐regulation of mitochondrial uncoupling protein 3 reveals an early muscular metabolic defect in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Hyperactive intracellular calcium signaling associated with localized mitochondrial defects in skeletal muscle of an animal model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Skeletal Muscle Is a Primary Target of SOD1G93A-Mediated Toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

ALS: a disease of motor neurons and their nonneuronal neighbors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Lathyrism: evidence for role of the neuroexcitatory aminoacid BOAA.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Studies on the etiology and pathogenesis of motor neuron diseases. II. Clinical and electrophysiologic features of pyramidal dysfunction in macaques fed Lathyrus sativus and IDPN.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Konzo, an epidemic upper motor neuron disease studied in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Cassava cyanogens and konzo, an upper motoneuron disease found in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Mechanisms of exercise-induced mitochondrial biogenesis in skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

HIF-1: upstream and downstream of cancer metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Amyotrophic lateral sclerosis-like conditions in possible association with cholesterol-lowering drugs: an analysis of patient reports to the University of California, San Diego (UCSD) Statin Effects Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Statins and amyotrophic lateral sclerosis--the level of evidence for an association

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Are statin medications safe in patients with ALS?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Nutritional management in MND/ALS patients: an evidence based review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the Am

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Assessing and predicting successful tube placement outcomes in ALS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Nasogastric feeding in the management of severe dysphagia in motor neurone disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Enteral and parenteral nutrition in the later stages of ALS: An observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970224-6

7 January 2021

Lathyrism and western Pacific amyotrophic lateral sclerosis: etiology of short and long latency motor system disorders

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(10)70224-6

High metabolic level in patients with familial amyotrophic lateral sclerosis

17 August 2024

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(10)70224-6

Anterior horn cell changes in a case of neurolathyrism

17 August 2024

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(10)70224-6

17 August 2024

Identifiers

DOI

1 reference

23 August 2017

1 reference